semaglutide being banned A South African court has ordered pharmacy group iDexis to stop selling semaglutide-based medicines. The ruling follows a legal challenge by Novo Nordisk, maker of Ozempic and Wegovy. Novo alleged the company Belgium bans Ozempic prescription for

Metsera comes furnished with injectable and oral forms of all these, sans muscle preservers, providing Pfizer with a healthy palette of diverse molecules to help address multiple customer segments within obesity, but more importantly, the wide swath of adjacent diseases where GLP-1 based treatment has started to show therapeutic promise

Not everybody responds the same way to the treatment and individual results will vary

S., Li, Q

J Pharm Investig 53:869879

First cardiovascular safety trial of a DPP-4 inhibitor in patients with T2DM and high cardiovascular risk, showing that saxagliptin does not augment MACE but increases hospitalization for heart failure

doi: 10.1007/s12328-017-0813-5 10 YuLXSchwabeRF